NSAIDs-- or nonsteroidal anti-inflammatory drugs -- are among the most common pain relief medicines in the world. Every day more than 30 million Americans use them to soothe headaches, sprains ...

The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

A new opioid-free pain medication was approved by the U.S. Food ... more than 80 million Americans annually and is the most common reason for emergency department visits, according to statistics.

The FDA has approved Journavx, a new non-opioid pain medication designed to reduce addiction and overdose risks.

The drug, Journavx, from Vertex Pharmaceuticals, reduced pain after surgery in clinical trials. Experts hope it can lead to fewer opioid prescriptions.

The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side effects.

Acute and chronic postoperative pain and functional disability persisted among patients who underwent posterior spinal fusion despite multimodal analgesic management.

Patients who experience musculoskeletal pain have many pharmaceutical options for relief — unless they also suffer from ...

Ibuprofen, a common painkiller, is found to boost memory and intelligence in a University College London study. While some ...